EUDA Health Holdings Limited (EUDA) Insider Trading Activity

NASDAQ$16.06
Market Cap
$29.99M
Sector
Healthcare
Industry
Medical—Healthcare Information Services
Rank in Sector
565 of 870
Rank in Industry
23 of 38

EUDA Insider Trading Activity

EUDA Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
Sells
$0
0

Related Transactions

About EUDA Health Holdings Limited

EUDA Health Limited develops digital health platform that offers virtual consults for non-emergency medical issues. The company was founded in 2019 and is based in Singapore. EUDA Health Limited company operates as a subsidiary of Watermark Developments Limited.

Insider Activity of EUDA Health Holdings Limited

Over the last 12 months, insiders at EUDA Health Holdings Limited have bought $0 and sold $0 worth of EUDA Health Holdings Limited stock.

On average, over the past 5 years, insiders at EUDA Health Holdings Limited have bought $0 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 292,250 shares for transaction amount of $0 was made by Tan Meng Dong (James) (director) on 2021‑11‑24.

List of Insider Buy and Sell Transactions, EUDA Health Holdings Limited

2021-11-24PurchaseTan Meng Dong (James)director
292,250
$0
$0
+122.52%
Total: 1

EUDA Institutional Investors: Active Positions

Increased Positions2+33.33%26,351+6.84%
Decreased Positions2-33.33%364,631-94.62%
New Positions<1New25,675New
Sold Out Positions2Sold Out364,631Sold Out
Total Postitions60%47,073-87.78%

EUDA Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Hudson Bay Capital Management Lp$787.000.84%320,000-476,100-59.8%2025-09-30
Citadel Advisors Llc$110.000.12%44,631+16,321+57.65%2025-09-30
Geode Capital Management, Llc$51.000.05%20,664+4,626+28.84%2025-09-30
Ubs Group Ag$00%48-4,551-98.96%2025-09-30
Sbi Securities Co., Ltd.$00%10+10New2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.